ASAP announces new teams joining the Collaborative Research Network! Learn More
Aligning Science Across Parkinson's Logo Text

Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration

Output Details

Preprint May 23, 2024

Published August 26, 2025

Parkinson’s disease (PD) is characterized by the death of substantia nigra pars compacta (SNc) dopamine (DA) neurons, but the pathophysiological mechanisms that precede and drive their death remain unknown. The activity of DA neurons is likely altered in PD, but we understand little about if or how chronic changes in activity may contribute to degeneration. To address this question, we developed a chemogenetic (DREADD) mouse model to chronically increase DA neuron activity and confirmed this increase using ex vivo electrophysiology. Chronic hyperactivation of DA neurons resulted in prolonged increases in locomotor activity during the light cycle and decreases during the dark cycle, consistent with chronic changes in DA release and circadian disturbances. We also observed early, preferential degeneration of SNc projections, recapitulating the PD hallmarks of selective vulnerability of SNc axons and the comparative resilience of ventral tegmental area axons. This was followed by the eventual loss of midbrain DA neurons. Continuous DREADD activation resulted in a sustained increase in baseline calcium levels, supporting a role for increased calcium in the neurodegeneration process. Finally, spatial transcriptomics from DREADD mice examining midbrain DA neurons and striatal targets, and cross-validation with human patient samples, provided insights into potential mechanisms of hyperactivity-induced toxicity and PD. Our results thus reveal the preferential vulnerability of SNc DA neurons to increased neural activity and support a potential role for increased neural activity in driving degeneration in PD.
Identifier (DOI)
10.7554/eLife.98775.3
Tags
  • Original Research

Meet the Authors

  • User avatar fallback logo

    Katerina Rademacher

    External Collaborator

  • User avatar fallback logo

    Zak Doric

    External Collaborator

  • User avatar fallback logo

    Dominik Haddad

    External Collaborator

  • User avatar fallback logo

    Aphroditi Mamaligas

    External Collaborator

  • User avatar fallback logo

    Liao Szu-Chi

    External Collaborator

  • User avatar fallback logo

    Rose Creed

    External Collaborator

  • User avatar fallback logo

    Kohei Kano

    External Collaborator

  • User avatar fallback logo

    Zac Chatterton

    External Collaborator

  • User avatar fallback logo

    YuHong Fu

    External Collaborator

  • User avatar fallback logo

    Joseph Garcia

    External Collaborator

  • User avatar fallback logo

    Victoria Vance

    External Collaborator

  • User avatar fallback logo

    Yoshitaka Sei

    External Collaborator

  • User avatar fallback logo

    Anatol Kreitzer

    External Collaborator

  • Glenda Halliday, PhD

    Co-PI (Core Leadership): Team Kirik Team Vila Team Edwards

    Macquarie University

  • Alexandra Nelson, MD, PhD

    Co-PI (Core Leadership): Team Edwards

    UC San Francisco

  • User avatar fallback logo

    Elyssa Margolis

    External Collaborator

  • Ken Nakamura, MD, PhD

    Co-PI (Core Leadership): Team Edwards

    University of California, San Francisco, Gladstone Institutes

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.